Stock Price
8.49
Daily Change
-0.06 -0.70%
Monthly
10.69%
Yearly
-58.40%
Q3 Forecast
8.48

Prothena reported $0 in Interest Expense on Debt for its fiscal quarter ending in June of 2024.




Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 3.01M 10.05M Dec/2024
ALKERMES USD 0 0 Jun/2025
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Amgen USD 694M 29M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Exelixis USD 23.4M 3.9M Sep/2023
Incyte USD 594K 66K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
MacroGenics USD 802K 826K Jun/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Prothena USD 0 0 Jun/2024
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Ultragenyx Pharmaceutical USD 14.04M 1.48M Jun/2025
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025